|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Esmolol#Overdosage]]} |
| {{Esmolol}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Overdosage==
| |
| | |
| ===Signs and Symptoms of Overdose===
| |
| | |
| Overdoses of BREVIBLOC (Esmolol Hydrochloride) can cause cardiac and central nervous system effects. These effects may precipitate severe signs, symptoms, sequelae, and complications (for example, severe cardiac and [[respiratory failure]], including [[shock]] and [[coma]]), and may be fatal. Continuous monitoring of the patient is required.
| |
| | |
| '''Cardiac effects''' include [[bradycardia]],[[ atrioventricular block]] (1st -, 2nd -, 3rd degree), [[junctional rhythms]], intraventricular conduction delays, decreased cardiac contractility,[[ hypotension]], [[cardiac failure]] (including cardiogenic shock), [[cardiac arrest]]/[[asystole]], and [[pulseless electrical activity]].
| |
| | |
| '''Central nervous system''' effects include [[respiratory depression]],[[ seizures]], sleep and mood disturbances, [[fatigue]], [[lethargy]], and [[coma]].
| |
| In addition, [[bronchospasm]], [[mesenteric ischemia]], peripheral [[cyanosis]], [[hyperkalemia]], and [[hypoglycemia ]](especially in children) may occur.
| |
| | |
| ==Treatment Recommendations==
| |
| | |
| Because of its approximately 9-minute elimination half-life, the first step in the management of toxicity should be to discontinue the BREVIBLOC infusion. Then, based on the observed clinical effects, consider the following general measures.
| |
| | |
| ===Bradycardia===
| |
| Consider intravenous administration of [[atropine]] or another [[anticholinergic]] drug or [[cardiac pacing]].
| |
| | |
| ===Cardiac Failure===
| |
| Consider intravenous administration of a [[diuretic]] or [[digitalis]] glycoside. In shock resulting from inadequate cardiac contractility, consider intravenous administration of [[dopamine]], [[dobutamine]], [[isoproterenol]], or [[inamrinone]]. [[Glucagon]] has been reported to be useful.
| |
| | |
| ===Symptomatic hypotension===
| |
| Consider intravenous administration of fluids or vasopressor agents such as [[dopamine]] or [[norepinephrine]].
| |
| | |
| ===Bronchospasm===
| |
| Consider intravenous administration of a [[beta 2]] stimulating agent or a [[theophylline]] derivative.
| |
| | |
| ===Dilution Errors===
| |
| Massive accidental overdoses of BREVIBLOC have resulted from dilution errors. Use of BREVIBLOC PREMIXED Injection and BREVIBLOC DOUBLE STRENGTH PREMIXED Injection may reduce the potential for dilution errors. Some of these overdoses have been fatal while others resulted in permanent disability. Bolus doses in the range of 625 mg to 2.5 g (12.5-50 mg/kg) have been fatal. Patients have recovered completely from overdoses as high as 1.75 g given over one minute or doses of 7.5 g given over one hour for cardiovascular surgery. The patients who survived appear to be those whose circulation could be supported until the effects of BREVIBLOC resolved.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref>
| |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
|
| |
|
| | [[Category:Beta blockers]] |
| | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |